PipelineReview.com - All Products

Show Cart

All Products

Results 1 - 20 of 170

Oct 2019 Flat-Rate Subscription to La Merie Publishing Reports

Dec 2018 TFPI Inhibitors – Target Pipeline List

Dec 2018 Interleukin-33/Receptor Targeted Antibodies – Target Pipeline List 12/2018

Nov 2018 Neulasta Biosimilars – Target Pipeline List 11/2018

Nov 2018 Avastin Biosimilars - Target Pipeline List 11/2018

Nov 2018 MerTK Inhibitors – Target Pipeline List 11/2018

Nov 2018 Humira Biosimilars – Target Pipeline List 11/2018

Aug 2018 CD40 Antagonists & CD40L Inhibitors – Target Pipeline List 08/2018

Aug 2018 Myostatin Inhibitors – Target Pipeline List 08/2018

Aug 2018 Interleukin-2 Receptor Agonists – Target Pipeline List 08/2018

Aug 2018 LRRK2 Inhibitors – Target Pipeline List 08/2018

Jul 2018 Antibody Target, Technology & Pipeline Database: 1-Year Subscription

Jul 2018 CXCR2, CCR2 & CCR4 Chemokine Receptor Antagonists – Target Pipeline List 07/2018

Jul 2018 Report Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators

(Discount: 40.00%)

Jul 2018 Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-β, CXCR4, CSF-1R, CD47-SIRPα, adenosine pathway & STING 2018

Jul 2018 CXCR4 Chemokine Receptor Antagonists – Target Pipeline List 07/2018

Jul 2018 Aryl Hydrocarbon Receptor (AHR) Agonists & Antagonists – Target Pipeline List 07/2018

Jul 2018 Novel IDO & TDO Inhibitors – Target Pipeline List 07/2018

Jul 2018 CSF-1R ( Colony Stimulating Factor 1 Receptor) Antagonists – Target Pipeline List 07/2018

Jul 2018 TGF-beta Inhibitors – Target Pipeline List 07/2018

Start
Prev
1
2
3
4
5
6
7
8
9
Next
End

Shopping cart

Cart empty

Latest report

Competitor Analysis: Next Wave Biosimilar Antibodies of Lucentis, Eylea, Xolair, Prolia, Stelara, Soliris and More

Featured Products

RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Bispecific Antibodies for Immuno-Oncology & Other Diseases

T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis

Latest Target Pipeline

CD38-Targeted Antibody & Cell Therapy

Shopping cart

Cart empty

Latest report

Competitor Analysis: Next Wave Biosimilar Antibodies of Lucentis, Eylea, Xolair, Prolia, Stelara, Soliris and More

Featured Products

RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Bispecific Antibodies for Immuno-Oncology & Other Diseases

T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis

Latest Target Pipeline

CD38-Targeted Antibody & Cell Therapy

La Merie Biologics

FREE Weekly News Bulletin

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing